First injectable nanoparticle generator could radically transform metastatic breast cancer treatment
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology (early online edition).
FIRST RAPID DETECTION ZIKA TEST NOW AVAILABLE THROUGH COLLABORATION WITH TEXAS CHILDREN’S HOSPITAL AND HOUSTON METHODIST HOSPITAL
Collaboration between two Texas Medical Center institutions has resulted in today’s release of the country’s first hospital-based rapid tests for the Zika virus.
DEMENTIA TREATMENT DELAYED DUE TO MISDIAGNOSIS
Many patients showing signs of dementia are quickly diagnosed with Alzheimer’s disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.